Sunday, January 29, 2023

How clinical trials get a pandemic push? ⭐

Date:

How have clinical trials received a pandemic boost for product development? The pandemic has given a strong tailwind to the clinical trials market, which is now valued at over US$67 billion, according to CB Insights. The game is to speed up product development using big data and artificial intelligence (AI), crunching time to market. Clinical trials involve a lengthy process of the regulatory approval process for drugs, devices, and digital therapies. However, the time and cost to complete them are prohibitive, and the likelihood of regulatory approval is low. This is where technology is coming into play to accelerate clinical trials and quicken drug development, besides enhancing the accuracy of the outcome of the trials. Real-W...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Popular

More like this
Related

Leader-shift for a hybrid world of work

Work must be refashioned into being purposeful to start...

2023: A turning point for FinTech, RegTech and Compliance?

Compliance is an ever-increasing challenge of introducing tech into...

Fallacies of forecasting and a forecast

Economists have rather unceremoniously struggled with their forecasts. But...

2023 will be the year of Edge AI

The year 2023 will be the age of Edge...